GGrantIndex
Sort

23,748 grants matching melanoma

Cyclin D1 function in tumorigenesis and differentiation

$351,920
Mark E Ewen · Dana-Farber Cancer Inst · R01 · FY2009 · CA

Mechanisms of Selective Therapeutic Synergy of PARP-inhibition and CTLA4 Blockade Engaged by Interferon-gamma in the Ovarian Tumor Microenvironment

$351,908
Sarah Foster Adams · University Of New Mexico Health Scis Ctr · R37 · FY2025 · CA

Adoptive T Cell Therapy Following CD25 Lymphodepletion

$351,887
Cassian Yee · Fred Hutchinson Cancer Research Center · R21 · FY2009 · CA

(PQD1) Clonal heterogeneity and targeted therapy resistance in melanoma

$351,883
Aleksandar None Sekulic · Mayo Clinic Arizona · R01 · FY2016 · CA

CD8+ T Cell-Mediated Immunotherapy of Autochthonous SV40 T Antigen-Induced Tumors

$351,876
Todd D Schell · Pennsylvania State Univ Hershey Med Ctr · R01 · FY2013 · CA

MC1R basis of melanoma-Parkinson's link and neuroprotective potential of MC1R

$351,865
Xiqun Chen · Massachusetts General Hospital · R01 · FY2020 · NS

RISK PREDICTION MODELS FOR RARE MELANOMAS

$351,764
Melanoma Research Alliance Foundation · · FY2021 · Defense Health Agency

CALGB

$351,751
Ohio State University · U10 · FY2001 · CA

Project 4-Modulating Innate Immunity to Overcome Resistance to PD-1/PD-L1 Blockade

$351,750
Harriet M Kluger · Yale University · P50 · FY2018 · CA

Mechanisms of durable antitumor immunity via CD26hiCD4+ T cells

$351,747
Chrystal Mary Paulos · Medical University Of South Carolina · R01 · FY2016 · CA

The Melanocortinergic pathway inglomerular disease

$351,745
Rujun Gong · University Of Toledo Health Sci Campus · R01 · FY2020 · DK

Matrix metalloproteinase-2 modulates inflammation via TLR2

$351,713
Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2016 · CA

Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis

$351,713
Eva Hernando · New York University School Of Medicine · R01 · FY2015 · CA

Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis

$351,713
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2016 · CA

Function of ATF2 URE binding protein in human melanoma

$351,713
Mount Sinai School Of Medicine Of Nyu · R01 · FY2002 · CA

Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis

$351,713
Eva Hernando · New York University School Of Medicine · R01 · FY2016 · CA

Function of ATF2 URE binding protein in human melanoma

$351,713
Mount Sinai School Of Medicine Of Nyu · R01 · FY2004 · CA

Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis

$351,713
Eva Hernando · New York University School Of Medicine · R01 · FY2013 · CA

Function of ATF2 URE binding protein in human melanoma

$351,713
Mount Sinai School Of Medicine Of Nyu · R01 · FY2003 · CA

Prognostic and Functional Role of microRNAs in Melanoma Brain Metastasis

$351,713
Eva Hernando · New York University School Of Medicine · R01 · FY2017 · CA

Transgenic in vivo delivery of MDA7/IL24 for maligannt glioma therapy

$351,713
Isabelle M Germano · Icahn School Of Medicine At Mount Sinai · R01 · FY2009 · CA

Matrix metalloproteinase-2 modulates inflammation via TLR2

$351,713
Nina Bhardwaj · Icahn School Of Medicine At Mount Sinai · R01 · FY2018 · CA

Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis

$351,713
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2013 · CA

Exosome-mediated Transfer of c-MET to Bone Marrow Progenitors Promotes Metastasis

$351,713
David Charles Lyden · Weill Medical Coll Of Cornell Univ · R01 · FY2017 · CA

MC1R basis of melanoma-Parkinson's link and neuroprotective potential of MC1R

$351,713
Xiqun Chen · Massachusetts General Hospital · R01 · FY2021 · NS